The Minos™ Abdominal Aortic Stent Graft and Delivery System (Minos™), developed by Endovastec™, recently received CE MDR (Medical Device Regulation (EU) 2017/745) certification and market approval in Egypt - a milestone in its global market expansion.

Minos™ was previously certified under the former CE MDD (Medical Device Directive 93/42/EEC). Designed for endovascular treatment of abdominal aortic aneurysms with a proximal neck length ≥15 mm, Minos™ offers strong performance in complex anatomies, including short or angulated necks and narrowed or tortuous access vessels. The device is currently in clinical use across 26 countries.

Endovastec™ remains committed to advancing its globalization strategy by delivering high-quality, innovative products to more countries, enhancing access and improving outcomes for patients with aortic and peripheral vascular diseases worldwide.